Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion
NCT ID: NCT03127657
Last Updated: 2018-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
25 participants
INTERVENTIONAL
2016-01-17
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic Dermatosis
NCT06763367
Topical Tripterygium Wilfordii Gel for Moderate Activity Rheumatoid Arthritis
NCT02818361
The Evaluation of Chenopodium Formosanum and Fagopyrum Esculentum Extract on Anti-aging Effect
NCT04237818
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
NCT00755326
A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks
NCT06274450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cock's comb extract 0.01%
25 Patients Cock's comb extract 0.01% Applied topically twice daily for 12 weeks
Cock's comb extract 0.01%
Applied topically twice daily for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cock's comb extract 0.01%
Applied topically twice daily for 12 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sex: Both male and female
* Arsenical keratosis: Presence of severe keratosis (\>5mm) in both palms
* Drinking arsenic contaminated water (\>50 µg/L) for at least more than 6 months
* Patient voluntarily agreed to participate
* Patient who understood the instruction of applying drug and could apply drug as per as instruction
Exclusion Criteria
* Pregnant and nursing mother
* Palmar psoriasis
* Eczema
* Any kind of systemic disease, inflammatory disease and infectious condition that affect skin for example diabetes mellitus, rheumatoid arthritis, systemic lupus erythrematosus, hepatitis
* Hypersensitivity to avain protein
* Malignancy
* Impaired renal function - if creatinine level \>1.3 mg/dl incase of men and \>1.1 mg/dl in case of women
* Patient who received any treatment of arsenicosis within last three months
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Mir Misbahuddin
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatema Chowdhury, MBBS
Role: PRINCIPAL_INVESTIGATOR
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shahrashti
Chāndpur, , Bangladesh
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BSMMU-011-CT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.